AMN Healthcare Services Inc (AMN)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $1.47B
Last updated: Nov 17, 2026 at 11:05 AM ET
AMN Healthcare Services Inc (AMN) Earnings: Report Dates and Results
AMN Healthcare Services (AMN) is expected to report earnings on Feb 17, 2027. In the quarter ended Sep 30, 2026, AMN Healthcare Services reported EPS of $1.16, above the $0.22 estimate. It beat the EPS estimate in 7 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
AMN has an expected report date of Feb 17, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 4.5% below the $0.22 reported for the quarter ended Dec 31, 2025.
AMN Earnings Call
The latest AMN earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, AMN beat 38, missed 1 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $717.27M, up 13.0% from $634.50M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $1.16 | $0.22 | $0.18 - $0.25 | +427.27% | Beat | +197.4% | 9 | 8 up, 1 down | Nov 5, 2026 | $717.27M |
| Jun 30, 2026 | $0.77 | $0.22 | $0.16 - $0.24 | +250.00% | Beat | +156.7% | 9 | 9 up, 0 down | Aug 6, 2026 | $673.24M |
| Mar 31, 2026 | $2.10 | $1.62 | $1.55 - $1.72 | +29.63% | Beat | +366.7% | 9 | 8 up, 0 down | May 7, 2026 | $1.38B |
| Dec 31, 2025 | $0.22 | $0.27 | $0.19 - $0.35 | -18.52% | Miss | -70.7% | 9 | 5 up, 0 down | Feb 19, 2026 | $748.23M |
| Sep 30, 2025 | $0.39 | $0.20 | $0.15 - $0.27 | +95.00% | Beat | -36.1% | 9 | 0 up, 1 down | Nov 6, 2025 | $634.50M |
| Jun 30, 2025 | $0.30 | $0.17 | $0.11 - $0.23 | +76.47% | Beat | -69.4% | 8 | 1 up, 1 down | Aug 7, 2025 | $658.17M |
| Mar 31, 2025 | $0.45 | $0.21 | $0.13 - $0.27 | +114.29% | Beat | -53.6% | 8 | 1 up, 1 down | May 8, 2025 | $689.53M |
| Dec 31, 2024 | $0.75 | $0.49 | $0.36 - $0.60 | +53.06% | Beat | -43.2% | 9 | 0 up, 9 down | Feb 20, 2025 | $734.71M |
| Sep 30, 2024 | $0.61 | $0.57 | $0.51 - $0.62 | +7.02% | Beat | -69.0% | 9 | 1 up, 0 down | Nov 7, 2024 | $687.51M |
| Jun 30, 2024 | $0.98 | $0.78 | $0.63 - $0.83 | +25.64% | Beat | -58.8% | 9 | 0 up, 0 down | Aug 8, 2024 | $740.68M |
| Mar 31, 2024 | $0.97 | $0.96 | $0.80 - $1.14 | +1.04% | Beat | -61.0% | 9 | 1 up, 0 down | May 9, 2024 | $820.88M |
| Dec 31, 2023 | $1.32 | $1.25 | $1.19 - $1.33 | +5.60% | Beat | -46.8% | 9 | 1 up, 0 down | Feb 15, 2024 | $818.27M |
| Sep 30, 2023 | $1.97 | $1.63 | $1.56 - $1.69 | +20.86% | Beat | -23.3% | 7 | 0 up, 0 down | Nov 2, 2023 | $853.46M |
| Jun 30, 2023 | $2.38 | $2.15 | $2.07 - $2.19 | +10.70% | Beat | -28.1% | 8 | 2 up, 0 down | Aug 3, 2023 | $991.30M |
| Mar 31, 2023 | $2.49 | $2.36 | $2.21 - $2.51 | +5.51% | Beat | -28.7% | 8 | 0 up, 0 down | May 4, 2023 | $1.13B |
| Dec 31, 2022 | $2.48 | $2.19 | $1.75 - $2.26 | +13.24% | Beat | -15.9% | 9 | 1 up, 0 down | Feb 16, 2023 | $1.13B |
| Sep 30, 2022 | $2.57 | $2.40 | $2.09 - $2.47 | +7.08% | Beat | +48.6% | 9 | 1 up, 0 down | Nov 3, 2022 | $1.14B |
| Jun 30, 2022 | $3.31 | $2.99 | $2.76 - $3.08 | +10.70% | Beat | +101.8% | 9 | 0 up, 0 down | Aug 4, 2022 | $1.43B |
| Mar 31, 2022 | $3.49 | $3.23 | $2.94 - $3.29 | +8.05% | Beat | +105.3% | 9 | 0 up, 0 down | May 5, 2022 | $1.55B |
| Dec 31, 2021 | $2.95 | $2.69 | $2.19 - $3.04 | +9.67% | Beat | +195.0% | 9 | 1 up, 0 down | Feb 17, 2022 | $1.36B |
| Sep 30, 2021 | $1.73 | $1.33 | $1.13 - $1.43 | +30.08% | Beat | +111.0% | 9 | N/A | Nov 4, 2021 | $877.80M |
| Jun 30, 2021 | $1.64 | $1.46 | $1.17 - $1.49 | +12.33% | Beat | +97.6% | 10 | N/A | Aug 5, 2021 | $857.45M |
| Mar 31, 2021 | $1.70 | $1.37 | $1.32 - $1.40 | +24.09% | Beat | +115.2% | 8 | N/A | May 6, 2021 | $885.95M |
| Dec 31, 2020 | $1.00 | $0.88 | $0.80 - $0.97 | +13.64% | Beat | +17.6% | 9 | N/A | Feb 18, 2021 | $631.27M |
| Sep 30, 2020 | $0.82 | $0.69 | $0.63 - $0.73 | +18.84% | Beat | +1.2% | 9 | N/A | Nov 5, 2020 | $551.63M |
| Jun 30, 2020 | $0.83 | $0.64 | $0.62 - $0.66 | +29.69% | Beat | +7.8% | 7 | N/A | Aug 6, 2020 | $608.35M |
| Mar 31, 2020 | $0.79 | $0.78 | $0.75 - $0.82 | +1.28% | Beat | +5.3% | 8 | N/A | May 11, 2020 | $602.46M |
| Dec 31, 2019 | $0.85 | $0.75 | $0.59 - $0.76 | +13.33% | Beat | +4.9% | 9 | N/A | Feb 13, 2020 | $586.89M |
| Sep 30, 2019 | $0.81 | $0.73 | $0.59 - $0.75 | +10.96% | Beat | -3.6% | 9 | N/A | Oct 31, 2019 | $567.60M |
| Jun 30, 2019 | $0.77 | $0.71 | $0.58 - $0.71 | +8.45% | Beat | -7.2% | 9 | N/A | Aug 6, 2019 | $535.18M |
| Mar 31, 2019 | $0.75 | $0.69 | $0.57 - $0.76 | +8.70% | Beat | -7.4% | 9 | N/A | May 2, 2019 | $532.44M |
| Dec 31, 2018 | $0.81 | $0.79 | $0.77 - $0.80 | +2.53% | Beat | +28.6% | 9 | N/A | Feb 14, 2019 | $528.63M |
| Sep 30, 2018 | $0.84 | $0.76 | $0.69 - $0.78 | +10.53% | Beat | +33.3% | 10 | N/A | Oct 31, 2018 | $526.84M |
| Jun 30, 2018 | $0.83 | $0.78 | $0.77 - $0.80 | +6.41% | Beat | +23.9% | 8 | N/A | Aug 2, 2018 | $558.11M |
| Mar 31, 2018 | $0.81 | $0.79 | $0.78 - $0.80 | +2.53% | Beat | +28.6% | 8 | N/A | May 3, 2018 | $522.49M |
| Dec 31, 2017 | $0.63 | $0.63 | $0.61 - $0.67 | 0.00% | In line | +1.6% | 8 | N/A | Feb 15, 2018 | $509.08M |
| Sep 30, 2017 | $0.63 | $0.60 | N/A | +5.00% | Beat | +1.6% | N/A | N/A | Nov 2, 2017 | $494.41M |
| Jun 30, 2017 | $0.67 | $0.60 | N/A | +11.67% | Beat | +9.8% | N/A | N/A | Aug 3, 2017 | $489.80M |
| Mar 31, 2017 | $0.63 | $0.61 | N/A | +3.28% | Beat | +5.0% | N/A | N/A | May 4, 2017 | $495.17M |
| Dec 31, 2016 | $0.62 | $0.54 | N/A | +14.81% | Beat | +31.9% | N/A | N/A | Feb 16, 2017 | $487.86M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $1.36, down 58.9% from the year before. It was $2.45 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $1.36 | -58.9% |
| Dec 31, 2024 | $3.31 | -59.4% |
| Dec 31, 2023 | $8.16 | -31.1% |
| Dec 31, 2022 | $11.85 | +47.8% |
| Dec 31, 2021 | $8.02 | +133.1% |
| Dec 31, 2020 | $3.44 | +8.2% |
| Dec 31, 2019 | $3.18 | -3.3% |
| Dec 31, 2018 | $3.29 | +28.5% |
| Dec 31, 2017 | $2.56 | +4.5% |
| Dec 31, 2016 | $2.45 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,400 words across 12 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,418 | 12 | |
| 2026Q2 | Jun 30, 2026 | 7,059 | 11 | |
| 2026Q1 | Mar 31, 2026 | 7,341 | 12 | |
| 2025Q4 | Dec 31, 2025 | 8,231 | 11 | |
| 2025Q3 | Sep 30, 2025 | 7,339 | 11 | |
| 2025Q2 | Jun 30, 2025 | 5,102 | 9 | |
| 2025Q1 | Mar 31, 2025 | 6,477 | 11 | |
| 2024Q4 | Dec 31, 2024 | 7,800 | 10 |
2026Q3 Earnings Call
Opening remarks
Randle G. Reece Vice President of Investor Relations Good afternoon, everyone. Welcome to AMN Healthcare's third quarter 2026 earnings call. A replay of this webcast will be available at ir.amnhealthcare.com. At the conclusion of this call, remarks we make about future expectations, projections, trends, plans, events, or circumstances constitute forward-looking statements. These statements reflect the Company's current beliefs based upon information currently available to it. Our actual results may differ materially from those indicated by these forward-looking statements because of various factors and cautionary statements, including those identified in our most recently filed Forms 10-K and 10-Q, our earnings release, and subsequent filings with the SEC. The Company does not intend to update guidance or any forward-looking statements provided today prior to its next earnings release. This call contains certain non-GAAP financial information. Information regarding, and reconciliations of, these non-GAAP measures to the most directly comparable GAAP measures are included in our earnings release and on our financial reports page at ir.amnhealthcare.com. On the call with me today are Caroline Sullivan Grace, President and Chief Executive Officer, and Brian Scott, Chief Financial and Operating Officer. I will now turn the call over to Carrie.
Caroline Sullivan Grace President and Chief Executive Officer AMN continued to deliver on our mission of empowering the future of care, as reflected in our third quarter results. Revenue of $717 million grew 13% year over year, or 6% excluding labor disruption activities. Revenue grew 27% from a year ago, or 15% without labor disruption. Search revenue saw 15% year-over-year revenue growth. Net income for the third quarter was $33 million, or $0.83 per share, and adjusted EBITDA was $94 million. Third quarter results included a $51 million favorable reserve adjustment for past labor disruption events. We see healthcare organizations taking a broader view of their workforce. While clients remain focused on cost and flexibility, increasingly they want better insights and visibility into demand, supply, and performance across their workforce. That plays to AMN's strengths. Our combination of talent depth, trusted client relationships, operational expertise, and technology-enabled solutions allows us to help clients not simply fill positions, but also make better workforce decisions. Underlying demand in most of our businesses continued to grow, and our teams executed well against this demand. Third quarter performance benefited from the market uplift, along with our company-specific gains in candidate acquisition and placements across sales channels. Five of our businesses have returned to year-over-year growth, and we see a path for the remaining businesses to return to growth in 2027. We are particularly encouraged by the growth in our Nurse and Allied business. Demand has strengthened, and our teams are capturing that demand through the improvements we have made in AI recruiting, speed, and 24/7 execution.
Frequently Asked Questions About AMN
When is AMN Healthcare Services's next earnings date?
AMN Healthcare Services's next earnings report is expected for Feb 17, 2027.
Did AMN beat earnings estimates last quarter?
Yes. AMN Healthcare Services reported EPS of $1.16 for the quarter ended Sep 30, 2026, above the $0.22 estimate, a 427.27% surprise.
What EPS do analysts expect from AMN next quarter?
The consensus EPS estimate for AMN Healthcare Services for the quarter ending Dec 31, 2026 is $0.21 from 10 analysts, with estimates from $0.15 to $0.34.
How often does AMN beat earnings estimates?
AMN Healthcare Services beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +128.40%.
AMN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts